Trial
NCT05946811
Macitentan to Prevent PRVO
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Pulmonary Embolism
Intervention
Macitentan 10mg
Why stopped
Study was cancelled by funding agency before starting enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-08